Communicable diseases intelligence quarterly report最新文献_第6页

Notifications of enteric diseases in returning travellers who visit friends and relatives overseas: a call for action. 在海外探亲访友的返港旅客中发生肠道疾病的通报：行动呼吁。

Communicable diseases intelligence quarterly report Pub Date : 2008-09-01 DOI: 10.33321/cdi.2008.32.34

Vicki G Slinko, Kari A J Jarvinen, Frank H Beard, Bradley J McCall

引用次数: 0

An evaluation of the Australian Rotavirus Surveillance Program. 澳大利亚轮状病毒监测计划的评价。

Communicable diseases intelligence quarterly report Pub Date : 2008-09-01 DOI: 10.33321/cdi.2008.32.33

April R Roberts-Witteveen, Mahomed S Patel, Paul W Roche

{"title":"An evaluation of the Australian Rotavirus Surveillance Program.","authors":"April R Roberts-Witteveen, Mahomed S Patel, Paul W Roche","doi":"10.33321/cdi.2008.32.33","DOIUrl":"10.33321/cdi.2008.32.33","url":null,"abstract":"The Australian Rotavirus Serotyping Program (ARSP) serotypes rotavirus isolates obtained from stool samples sent from Australian laboratories. In collaboration with ARSP the Australian Government Department of Health and Ageing evaluated the program for its utility and capacity to monitor effectiveness of the rotavirus vaccines recently introduced into the Australian National Immunisation Program. The system was described using ARSP annual reports and staff interviews. The attributes of the system were assessed by adapting standard guidelines for evaluating a surveillance system. Email surveys or face to face interviews were conducted with staff of ARSP, participating laboratories, rotavirus vaccine manufacturing companies and representatives of the Communicable Diseases Network Australia. The ability of the ARSP to monitor changes in rotavirus serotype epidemiology was assessed. ARSP serotypes rotavirus isolates received from participating laboratories at least bi-annually, with results being reported at least as often. Serotype analyses have informed formulation of rotavirus vaccines and contributed to forecasting the extent of outbreaks caused by novel serotypes. The ARSP will be able to monitor changes in rotavirus serotype epidemiology and identify probable vaccination failures. Enhancement of the representativeness and sensitivity of the system are needed for the data to remain useful in the public health context. Methods for transferring data between the program and state and territory health departments need to be developed.","PeriodicalId":350023,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":" ","pages":"326-32"},"PeriodicalIF":0.0,"publicationDate":"2008-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27884146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Annual report of the Australian Meningococcal Surveillance Programme, 2007. 2007年澳大利亚脑膜炎球菌监测规划年度报告。

IF 2.5

Communicable diseases intelligence quarterly report Pub Date : 2008-09-01

John Tapsall

{"title":"Annual report of the Australian Meningococcal Surveillance Programme, 2007.","authors":"John Tapsall","doi":"","DOIUrl":"","url":null,"abstract":"In 2007 there were 242 laboratory-confirmed cases of invasive meningococcal disease analysed by the National Neisseria Network, a nationwide network of reference laboratories. The phenotypes (serogroup, serotype and serosubtype) and antibiotic susceptibility of 127 isolates of Neisseria meningitidis from invasive cases of meningococcal disease were determined and an additional 115 cases were confirmed by non-culture based methods. Nationally, 192 (85%) confirmed cases where a serogroup was determined were infected with serogroup B and 14 (6.2%) with serogroup C meningococci. The total number of confirmed cases was 29 fewer than the 271 cases identified in 2006. The only jurisdiction to record a substantial increase in laboratory confirmed cases was New South Wales and this was in sporadic cases of serogroup B infection. Typical primary and secondary disease peaks were observed in those aged 4 years or less and in adolescents and young adults respectively. Serogroup B cases predominated in all age groups and jurisdictions. The common phenotypes circulating in Australia were B:15:P1.7, B:4:P1.4 and C:2a:P1.5. No evidence of meningococcal capsular 'switching' was detected. About three-quarters of all isolates showed decreased susceptibility to the penicillin group of antibiotics (minimum inhibitory concentration [MIC] 0.06-0.5 mg/L). All isolates remained susceptible to rifampicin. A single serogroup B isolate had decreased susceptibility to ciprofloxacin (MIC 0.06 mg/L). This was the first local isolate of this type since the original report of this phenomenon in Australia in 2000.","PeriodicalId":350023,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":" ","pages":"299-307"},"PeriodicalIF":2.5,"publicationDate":"2008-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27884141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

OzFoodNet quarterly report, 1 April to 30 June 2008. 2008年4月1日至6月30日的季度报告。

Communicable diseases intelligence quarterly report Pub Date : 2008-09-01 DOI: 10.33321/cdi.2008.32.35

引用次数: 0

Epidemiology of laboratory confirmed tuberculosis in Victoria, 1990 to 2004. 1990年至2004年维多利亚州实验室确认的结核病流行病学。

Communicable diseases intelligence quarterly report Pub Date : 2008-06-01 DOI: 10.33321/cdi.2008.32.22

Michelle E McPherson, David Leslie, Aina Sievers, Mahomed Patel, Heath Kelly

引用次数: 0

Enhanced case detection for newly acquired hepatitis C infection: epidemiological findings and health service implications. 加强对新获得的丙型肝炎感染的病例检测：流行病学调查结果和卫生服务影响。

Communicable diseases intelligence quarterly report Pub Date : 2008-06-01 DOI: 10.33321/cdi.2008.32.24

Rebecca Guy, Darshini Devadason, Megan Lim, Nasra Higgins, Alisa Pedrana, Katharine Gibson, Jenny Lewis, Tim Spelman, Bethany White, John Kaldor, Margaret Hellard

{"title":"Enhanced case detection for newly acquired hepatitis C infection: epidemiological findings and health service implications.","authors":"Rebecca Guy, Darshini Devadason, Megan Lim, Nasra Higgins, Alisa Pedrana, Katharine Gibson, Jenny Lewis, Tim Spelman, Bethany White, John Kaldor, Margaret Hellard","doi":"10.33321/cdi.2008.32.24","DOIUrl":"10.33321/cdi.2008.32.24","url":null,"abstract":"Identifying newly acquired hepatitis C infections and describing their epidemiological characteristics has public health importance but can be resource intensive. We developed a new approach to conducting surveillance for newly acquired hepatitis C infection and analysed the epidemiological findings and health service implications. Doctors and laboratories in the Australian state of Victoria are required by law to notify all hepatitis C diagnoses to the Department of Human Services, but the routine report is limited to basic demographic information. For all cases reported as being aged 16-19 years or having clinical or laboratory indicators of newly acquired infection, during the period July 2004 to December 2005, additional information was sought from diagnosing doctors and used to classify cases as 'newly acquired' or 'unspecified' using a standard case definition. Of the 4,561 hepatitis C notifications received by the Department during the study period, 415 (9%) were selected for follow up and 148 of these (36%) were classified as newly acquired infections, compared with 4%-10% achieved from previous systems. Based on the enhanced data collection, the most common risk factor for transmission among newly acquired infections was injecting drug use (86%), the median age was 23 years, 59% were males and the predominant reason for testing was drug and alcohol screening (32%). This surveillance system was much more efficient at detecting newly acquired cases of hepatitis C infection than other approaches used in Victoria. Initial results show that injecting drug use continues to be by far the predominant mode of hepatitis C transmission in Victoria.","PeriodicalId":350023,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":" ","pages":"250-6"},"PeriodicalIF":0.0,"publicationDate":"2008-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27654331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

OzFoodNet quarterly report, 1 January to 31 March 2008. 2008年1月1日至3月31日的季度报告。

Communicable diseases intelligence quarterly report Pub Date : 2008-06-01 DOI: 10.33321/cdi.2008.32.28

引用次数: 0

Prevalence of antimicrobial resistances in Streptococcus pneumoniae in Australia, 2005: report from the Australian Group on Antimicrobial Resistance. 2005年澳大利亚肺炎链球菌抗微生物药物耐药性流行情况：澳大利亚抗微生物药物耐药性小组报告

Communicable diseases intelligence quarterly report Pub Date : 2008-06-01 DOI: 10.33321/cdi.2008.32.23

Thomas Gottlieb, Peter J Collignon, Jennifer M Robson, Julie C Pearson, Jan M Bell

{"title":"Prevalence of antimicrobial resistances in Streptococcus pneumoniae in Australia, 2005: report from the Australian Group on Antimicrobial Resistance.","authors":"Thomas Gottlieb, Peter J Collignon, Jennifer M Robson, Julie C Pearson, Jan M Bell","doi":"10.33321/cdi.2008.32.23","DOIUrl":"10.33321/cdi.2008.32.23","url":null,"abstract":"In 2005 the Australian Group for Antimicrobial Resistance (AGAR) conducted a survey of the prevalence of antimicrobial resistance in unique clinical isolates of Streptococcus pneumoniae. Twenty laboratories from the 5 mainland states and the Australian Capital Territory collected 1,776 isolates prospectively and tested them by disk diffusion, Etest and/or agar dilution against a range of antimicrobials. Data from this survey were compared with AGAR surveys conducted in 1989, 1994, 1999 and 2002. Non-susceptibility to penicillin was detected in 28.0% of isolates, 22.7% were erythromycin resistant, 15.6% clindamycin resistant, 18.4% tetracycline resistant and 31.0% trimethoprim-sulphamethoxazole resistant. Levofloxacin resistance was detected in only 4 of 1,775 (0.2%) isolates tested. Intermediate resistance to levofloxacin was detected in another 4 isolates. Moxifloxacin resistance was present in 2 isolates with minimum inhibitory concentrations of 3 mg/L and 4 mg/L. Seventeen point three per cent of isolates were multi-resistant (acquired resistance to more than 2 drug classes). Trend data show an increase in penicillin non-susceptible strains in each survey from 1989 to 2005. Between 1999 and 2005 the proportion of invasive strains with high-level resistance increased from 2.6% to 5.4%. After a rapid emergence and rise in resistance between 1989 and 1999, recent studies have documented a continuing rise in resistance to all non-beta-lactams except trimethoprim-sulphamethoxazole.","PeriodicalId":350023,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":" ","pages":"242-9"},"PeriodicalIF":0.0,"publicationDate":"2008-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27654329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Australia's notifiable diseases status, 2006: annual report of the National Notifiable Diseases Surveillance System. 《2006年澳大利亚法定疾病状况：国家法定疾病监测系统年度报告》。

Communicable diseases intelligence quarterly report Pub Date : 2008-06-01 DOI: 10.33321/cdi.2008.32.18

Kylie Begg, Paul Roche, Rhonda Owen, Conan Liu, Marlena Kaczmarek, Aurysia Hii, Stefan Stirzaker, Ann McDonald, Gerard Fitzsimmons, Peter McIntyre, Robert Menzies, Iain East, David Coleman, Krissa O'Neil

引用次数: 0

Barmah Forest virus serology; implications for diagnosis and public health action. 巴玛森林病毒血清学；对诊断和公共卫生行动的影响。

Communicable diseases intelligence quarterly report Pub Date : 2008-06-01 DOI: 10.33321/cdi.2008.32.27

Patrick Cashman, Linda Hueston, David Durrheim, Peter Massey, Stephen Doggett, Richard C Russell

{"title":"Barmah Forest virus serology; implications for diagnosis and public health action.","authors":"Patrick Cashman, Linda Hueston, David Durrheim, Peter Massey, Stephen Doggett, Richard C Russell","doi":"10.33321/cdi.2008.32.27","DOIUrl":"10.33321/cdi.2008.32.27","url":null,"abstract":"Barmah Forest virus (BFV) is a commonly occurring arbovirus in Australia. Notifications of Barmah Forest infections diagnosed by a single positive IgM serology test have been increasing in coastal New South Wales north of Newcastle. We report on a 6 month prospective review of all routine notifications of BFV from the Lower Mid North Coast of New South Wales. Sera from 37 consecutive cases were sent for confirmatory testing by ELISA and neutralisation assays and 32 cases were interviewed. On confirmatory testing, 7 patients' sera (19%) was found to contain no BFV antibodies and 6 (16%) had BFV IgG only. Only 4 cases had antibody levels compatible with recent infection. A clinical presentation of fever with either rash or joint pain was associated with confirmation of recent BFV infection. On the basis of these findings, caution is advised in the interpretation of a single positive IgM for Barmah Forest disease and the clinical picture is an important factor in the diagnosis. Serological notifications of BFV alone should not prompt public health action such as public warning and targeted vector control in endemic areas.","PeriodicalId":350023,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":" ","pages":"263-6"},"PeriodicalIF":0.0,"publicationDate":"2008-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27654334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0